The group's co-authored "Construction and Acceptance Standard for Clean Rooms in the Pharmaceutical Industry" has been approved as a national standard.

Release time:

2025-05-23

The group's co-authored "Construction and Acceptance Standard for Clean Rooms in the Pharmaceutical Industry" has been approved as a national standard

On May 21, the group's co-authored "Construction and Acceptance Standard for Clean Rooms in the Pharmaceutical Industry" was approved as a national standard by the Ministry of Housing and Urban-Rural Development, with the number GB/T51466-2025, and will be implemented on September 1, 2025.
This standard is based on the original national standard for the construction of clean rooms in the pharmaceutical and electronics industries, and has been systematically optimized to meet the specific needs of the pharmaceutical industry. It emphasizes the process characteristics and technical requirements of pharmaceutical clean engineering. Jiangsu Qi'an, as a major participating unit, and Xu Bing, deputy general manager of the group, as a member of the standard drafting group, leveraged their years of experience in the pharmaceutical clean engineering field to provide professional technical content, including construction specifications for clean pipe systems, commissioning and testing standards for clean air conditioning systems, and acceptance procedures for clean color-coated steel plate enclosure structures. In particular, the innovative achievements accumulated by the company, such as CMA-certified clean room construction experience and the FDA standard clean room maintenance system, have been integrated into the standard clauses, making the new national standard more instructive and practical in terms of construction processes and acceptance indicators.
First-class enterprises set standards! This participation in the national standard fully demonstrates Jiangsu Qi'an's leading technical strength in the field of pharmaceutical clean engineering, provides strong technical support for the group's further expansion into strategic emerging markets such as biomedicine and high-end medical devices, and makes Jiangsu Qi'an's due contribution to promoting the standardization of China's pharmaceutical clean engineering. (Jinhui Branch)

Three QC achievements of the group won awards at the National Engineering Construction Quality Management Achievement Competition

Fifteen papers from the group company won awards from the provincial industry association.

Recommended news

2026-06-05

The Group’s Roche Pharmaceutical Project has been awarded the One-Million-Safety-Hours Award.

On June 5, the Roche (Shanghai) Biopharmaceutical Production Base Project (Phase I) held a ceremony to celebrate reaching one million safe man-hours, and the Group was presented with a commemorative trophy.

2026-05-26

The Group convened a special meeting of the dedicated task force for major project services.

On the afternoon of May 25, the Group convened a special working meeting on major project services in the 16th-floor conference room, with senior management and all members of the Major Project Management Department in attendance. The meeting was chaired by Zhang Jian, General Manager of the Group.

2026-05-26

The Jinshun Branch of the Group organized a project management observation and exchange event.

On May 23, the Jinshun Branch of the Group organized an on-site observation and exchange session on project management. All project managers, frontline supervisors, and relevant personnel from various functional departments of the branch attended the event, while selected managers from China State Construction Engineering Corporation Third Bureau and Xinjiang Production and Construction Corps Construction Engineering Company were invited to participate in the observation and discussion.

2026-05-09

Group General Manager Zhang Jian Visits Asahi Kasei (Nantong) to Deepen Cooperation and Exchange

On May 8, Zhang Jian, General Manager of the Group, led a delegation to Asahi Kasei Fine Chemicals (Nantong) Co., Ltd. for a project follow-up visit and exchange meeting, during which they held a symposium with Asahi Kasei General Manager Yuichi Sanro and other senior executives. Cai Ting and Gao Mingmin, Deputy General Managers of the Group, also attended the event.

2026-05-21

The Group has won the bid for the Fujian Yuanfu Technology project to produce 3,000 tons per year of high-purity lithium fluoride.

Recently, good news emerged from the southern market: the Group has successfully won the bid for Fujian Yuanfu Technology Co., Ltd.’s 3,000-ton-per-year high-purity lithium fluoride project under an EPC general contracting model, with a total contract value exceeding RMB 40 million.

2026-05-19

The Shanghai Wangyuan Building Hotel’s comprehensive renovation project has entered its final sprint.

In mid-May, the hotel renovation project for the Shanghai Wangyuan Building, undertaken by the Group, entered its final, critical phase of intensive completion. At present, all core construction tasks— including the main interior finishing works and the installation and commissioning of various mechanical and electrical systems—have been successfully completed. The project’s focus has now fully shifted to meticulous fine‑tuning, integrated system testing and commissioning, and comprehensive on‑site cleanup and final finishing.